| Record ID | harvard_bibliographic_metadata/ab.bib.11.20150123.full.mrc:434912594:1154 |
| Source | harvard_bibliographic_metadata |
| Download Link | /show-records/harvard_bibliographic_metadata/ab.bib.11.20150123.full.mrc:434912594:1154?format=raw |
LEADER: 01154cam a2200361Ia 4500
001 011487264-3
005 20090417043055.0
008 991004s1999 maua b 000 0 eng d
020 $a096739600X
020 $a9780967396002
035 0 $aocm42520665
040 $aDJB$cDJB$dOCLCQ$dYDXCP
043 $an-us---$af-tz---$aa-ai---$aa-ir---$aa-tu---$anwht---
090 $aHD9666.5$b.A88 1999
245 03 $aAn Assessment of US pharmaceutical donations :$bplayers, processes, and products /$cedited by Michael R. Reich.
260 $aBoston, Mass. :$bHarvard School of Public Health,$c1999.
300 $a280 p. :$bill. ;$c23 cm.
504 $aIncludes bibliographical references.
651 2 $aHaiti.
651 2 $aArmenia.
651 2 $aTanzania.
651 2 $aUnited States.
650 12 $aPharmaceutical Preparations.
650 12 $aDrug Industry.
650 0 $aPharmaceutical industry$zUnited States.
650 0 $aDrugs$zTanzania.
650 0 $aDrugs$zArmenia.
650 0 $aDrugs$zHaiti.
650 0 $aDrugs$zUnited States.
610 20 $aWorld Health Organization.
700 1 $aReich, Michael,$d1950-
988 $a20080610
906 $0OCLC